Quantum-Si incorporated

NASDAQ:QSI

Biotechnology

Healthcare
$1.01 +5.02%

+$0.05 today

Market cap
$201.80M
Beta
3.17
P/E (TTM)
-2.1
EPS (TTM)
-$0.48
52W Low $0.69High $3.10

Volume 5.35M

Average 5.64M

Fair Value & DCF

Compare our fair value with your own assumptions

Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.

Quantum-Si incorporated

NASDAQ:QSI

Intrinsic Alpha fair value

Locked

Current Price

$1.01

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.

Build your own valuation

Test an independent scenario and compare it with Intrinsic Alpha's estimate.

Sign in to use the DCF calculator

Free accounts get 5 valuations per week. Upgrade for more.

Sign in / Sign up

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
+112.6% (5yr)2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Forward estimates point to Revenue at +112.6% (5yr), giving you a quick read on expected growth from here.

Estimates & History

Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.

Further estimates hidden. Sign in to unlock

Competitor Valuations

Peer stocks ranked by intrinsic value status

CompanyMarket CapPriceValuationP/E1Y Return

LB Pharmaceuticals Inc Common Stock

NASDAQ:LBRX

$1.39B$43.01Not rated-21.4+153.14%

Solid Biosciences Inc.

NASDAQ:SLDB

$763.42M$6.84Not rated-4.3+39.37%

Aura Biosciences, Inc.

NASDAQ:AURA

$739.97M$7.11Not rated-3.7+32.16%

Annexon, Inc.

NASDAQ:ANNX

$642.26M$3.92Not rated-4.8+8.44%

Altimmune, Inc.

NASDAQ:ALT

$319.98M$1.65Not rated-3.7-67.10%

Autolus Therapeutics plc

NASDAQ:AUTL

$311.41M$1.17Not rated-1.4-15.50%

DBV Technologies S.A.

NASDAQ:DBVT

$263.50M$11.02Not rated-8.3-28.28%

Rocket Pharmaceuticals, Inc.

NASDAQ:RCKT

$252.48M$2.30Not rated-1.7-28.23%

ADC Therapeutics S.A.

NYSE:ADCT

$171.07M$1.34Not rated-1.2-66.25%

enGene Holdings Inc.

NASDAQ:ENGN

$161.51M$2.41Not rated-1.8-75.00%